Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2016 / Articles / May / Solving the challenges of Leachable pharmaceutical impurities using a full analytical portfolio
Discovery & Development Analytical Science

Solving the challenges of Leachable pharmaceutical impurities using a full analytical portfolio

05/04/2016 1 min read

Share

Stephen Guilfoyle (Pharma & Biopharma Marketing, Thermo Fisher Scientific) discusses developments in the regulatory landscape and a broad portfolio of tools to meet these challenges. Find out more about Extractables & Leachables testing at http://www.thermoscientific.com/en/community/extractables-leachables.html?ca=Leachables

Please log in or sign up to view video

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

Electrifying R&D Acceleration
Small Molecules Analytical Science
Electrifying R&D Acceleration

December 2, 2014

0 min read

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...

The Lab of the Future: Combining Automation with Digital Tools
Contract Development Services Analytical Science Technology and Equipment Digital Technologies
The Lab of the Future: Combining Automation with Digital Tools

February 25, 2025

6 min read

How do you scale up operations without adding headcount or significantly increasing investment in instrumentation? The answer: automation and workflow scheduling software.

SORS and the Power of Light in Pharma
Ingredients Analytical Science Technology and Equipment
SORS and the Power of Light in Pharma

January 17, 2025

7 min read

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more

Facing Up to the New Nemesis of Pharma: Nitrosamines
Quality & Compliance Small Molecules Process Control Analytical Science Ingredients
Facing Up to the New Nemesis of Pharma: Nitrosamines

September 5, 2024

8 min read

What’s going on with nitrosamines in pharmaceutical products? Naiffer Romero, Principal Scientist at the US Pharmacopeia walks us through frequently asked questions.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.